Eli Lilly & Co
Foundayo
adults with obesity, or overweight with weight-related medical problems
Resolved
68days ago
Approval decision Β· Apr 30, 2026
What's at stake
A final FDA approval decision on Foundayo for adults with obesity, or overweight with weight-related medical problems is expected Apr 30, 2026.
Primary source
Β· SEC 8-K
verified 15h ago
βU.S. FDA approval of Foundayo (orforglipron) for adults with obesity, or overweight with weight-related medical problems.β